J. Mark King, a long-time healthcare executive is the new Non-Executive/Non-Owner Chairman of the Board and Healthcare Industry Advisor for KMM Group.

King has held numerous executive leadership roles in the medical device Industry, both in branded product lines and in contract manufacturing. Most recently, he served as president and CEO of contract manufacturer Tegra Medical. Prior to Tegra, he was the president and CEO of Clinical Innovations, a market leader in the manufacture of medical devices focused on Women’s Health.

King holds a BS from the School of Technology at Purdue University and has completed executive education studies at University of Wisconsin and Duke University. He also sits on the Florida Medical Manufactures Consortium board of directors.

In his new role, King will provide guidance, pertaining to the medical device industry, to the KMM Group senior leadership team to help the company achieve its strategic goals.

“We are extremely fortunate to have the opportunity to engage with Mark King in this particular phase of the company’s growth,” said John Shegda, CEO of KMM Group. “KMM is well positioned to be a force in medical device contract manufacturing. My partner, Eric Wilhelm, and I hope to leverage Mark’s knowledge and experience to help realize the exciting vision we have had for more than a decade as individual business owners and for KMM Group which stands before us now.”